New COVID-19 test developed in Singapore detects past infection within an hour
A new COVID-19 test that can rapidly assess if a person has been previously infected with the coronavirus is now available to hospitals in Singapore....
Continue ReadingCarlyle and former Mylan top executive in talks to buy Ra Chem Pharma from Micro Labs
The Carlyle-Hari Babu consortium is in advanced stages of negotiations to buy out Hyderabad-based API ( active pharmaceutical ingredients) maker Ra Chem Pharma from majority...
Continue ReadingBGU researcher develops one-minute COVID-19 breath test
Ben-Gurion University of the Negev’s Prof. Gabby Sarusi has developed and is now validating a test that identifies carriers of the COVID-19 virus in less...
Continue ReadingThe race for coronavirus vaccines: a graphical guide
More than 90 vaccines are being developed against SARS-CoV-2 by research teams in companies and universities across the world. Researchers are trialling different technologies, some...
Continue ReadingJubilant Life Sciences Enters Into Licensing Agreement With Gilead For Remdesivir, Potential Therapy For Covid-19
Jubilant Life Sciences Limited has announced that its subsidiary, Jubilant Generics Limited, has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. that will...
Continue ReadingGlenmark initiates Phase 3 clinical trials on Favipiravir to check efficacy on COVID-19 patients
Glenmark PharmaceuticalsNSE 1.42 % on Tuesday said it has initiated Phase 3 clinical trials on antiviral drug Favipiravir to check its efficacy on COVID-19 patients...
Continue ReadingPremas Biotech announces development of vaccine against COVID-19
A team of researchers led by IIT Bombay alumnus Dr Prabuddha Kundu, at Gurgaon based Premas Biotech, is developing a triple antigen vaccine. They have...
Continue ReadingNatco Pharma gets EIR from USFDA for Telangana facility
USFDA had conducted pre-approval inspection at Natco’s facility in Kothur village from March 2-6, 2020 Natco Pharma has received an establishment inspection report (EIR) from...
Continue ReadingAn Expert Explains: ‘We need global access agreements before a vaccine is developed’
Dr Seth Berkley is CEO of Gavi — The Vaccine Alliance, a partner of the Bill & Melinda Gates Foundation, which works for better and...
Continue Reading